Compound Detail
CHEMBL1789941
RUXOLITINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1789941 |
| Name | RUXOLITINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HFNKQEVNSGCOJV-OAHLLOKOSA-N |
| Therapeutic | ✓ Yes |
152
Targets
379
Activities
4
Assay Types
5
PK Parameters
20
Publications
9
Known Names
20
Indications
Molecular Properties
306.4
MW (Da)
3.47
ALogP
5
HBA
1
HBD
83.2
PSA (Ų)
0.80
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2011 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Eczema Neoplasms Neoplasms Dermatitis, Atopic Graft vs Host Disease Graft vs Host Disease Lymphohistiocytosis, Hemophagocytic Macrophage Activation Syndrome Myeloproliferative Disorders Pancreatic Neoplasms Polycythemia Vera Primary Myelofibrosis Primary Myelofibrosis Prurigo Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Thrombocythemia, Essential Vitiligo Alopecia Areata Anemia
ATC Classification
D11AH09
ruxolitinib
Level 1: DERMATOLOGICALS
Level 2: OTHER DERMATOLOGICAL PREPARATIONS
L01EJ01
ruxolitinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
Kd 181 meas. best 10.44
IC50 175 meas. best 10.44
Ki 14 meas. best 10.05
EC50 9 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 10.44 | 8.4323 | 0.0 | 53 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | Kd | 10.44 | 8.8475 | 0.0 | 4 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 10.05 | 8.4972 | 0.1 | 36 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | Ki | 10.05 | 9.8167 | 0.1 | 3 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | Ki | 10.0 | 9.8733 | 0.1 | 3 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | IC50 | 9.4 | 8.0472 | 0.4 | 18 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | Ki | 9.3 | 9.29 | 0.5 | 4 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | Kd | 9.05 | 7.9533 | 0.9 | 3 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 8.7 | 6.8836 | 2.0 | 25 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | Kd | 8.7 | 8.135 | 2.0 | 2 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | Ki | 8.49 | 8.49 | 3.2 | 3 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | Kd | 8.47 | 8.095 | 3.4 | 2 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | EC50 | 8.0 | 8.0 | 10.0 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | EC50 | 7.92 | 7.0867 | 12.0 | 3 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 7.82 | 7.82 | 15.0 | 1 |
| JAK3/JAK1 CHEMBL3038491 | IC50 | 7.75 | 6.816 | 18.0 | 5 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | EC50 | 7.62 | 7.62 | 24.0 | 2 |
| JAK2/JAK1 CHEMBL3038492 | IC50 | 7.51 | 7.51 | 31.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 2 CHEMBL5914 | Kd | 7.39 | 7.39 | 41.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha CHEMBL4147 | Kd | 7.34 | 7.34 | 46.0 | 1 |
| Rho-associated protein kinase 2 CHEMBL2973 | Kd | 7.28 | 6.255 | 52.0 | 2 |
| Rho-associated protein kinase 1 CHEMBL3231 | Kd | 7.22 | 6.655 | 60.0 | 2 |
| JAK1/TYK2 CHEMBL3301391 | IC50 | 7.19 | 6.95 | 65.0 | 4 |
| Serine/threonine-protein kinase DCLK1 CHEMBL5683 | Kd | 7.17 | 7.17 | 68.0 | 1 |
| Death-associated protein kinase 1 CHEMBL2558 | Kd | 7.14 | 7.14 | 72.0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | Kd | 7.05 | 6.795 | 90.0 | 2 |
| Death-associated protein kinase 3 CHEMBL2468 | Kd | 7.05 | 7.05 | 89.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta CHEMBL2801 | Kd | 7.05 | 6.78 | 90.0 | 2 |
| Death-associated protein kinase 2 CHEMBL3123 | Kd | 7.01 | 7.01 | 97.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma CHEMBL3829 | Kd | 7.0 | 6.795 | 100.0 | 2 |
| AP2-associated protein kinase 1 CHEMBL3830 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Cyclin-G-associated kinase CHEMBL4355 | Kd | 7.0 | 5.875 | 99.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Ribosomal protein S6 kinase alpha-1 CHEMBL2553 | Kd | 6.92 | 5.995 | 120.0 | 2 |
| AP2-associated protein kinase 1 CHEMBL3830 | Kd | 6.92 | 5.97 | 120.0 | 3 |
| Cyclin-G-associated kinase CHEMBL4355 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type 1D CHEMBL5073 | Kd | 6.92 | 6.92 | 120.0 | 1 |
| BaF3 CHEMBL614524 | IC50 | 6.9 | 6.9 | 126.0 | 1 |
| Serine/threonine-protein kinase PLK1 CHEMBL3024 | Kd | 6.89 | 6.41 | 130.0 | 2 |
| Ribosomal protein S6 kinase alpha-5 CHEMBL4237 | Kd | 6.85 | 6.85 | 140.0 | 1 |
| Ribosomal protein S6 kinase alpha-2 CHEMBL3906 | Kd | 6.82 | 6.82 | 150.0 | 1 |
| Ribosomal protein S6 kinase alpha-6 CHEMBL4924 | Kd | 6.82 | 6.335 | 150.0 | 2 |
| Mitogen-activated protein kinase kinase kinase 3 CHEMBL5970 | Kd | 6.82 | 6.82 | 150.0 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL1649049 | EC50 | 6.73 | 6.73 | 186.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Kd | 6.72 | 6.284 | 190.0 | 5 |
| Serine/threonine-protein kinase ULK2 CHEMBL5435 | Kd | 6.72 | 6.72 | 190.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type IV CHEMBL2494 | Kd | 6.71 | 6.71 | 196.0 | 1 |
| Uncharacterized protein FLJ45252 CHEMBL4105933 | Kd | 6.71 | 6.71 | 196.0 | 1 |
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | Kd | 6.7 | 6.7 | 200.0 | 1 |
| Human immunodeficiency virus 2 CHEMBL380 | EC50 | 6.7 | 6.7 | 200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 315.9 | - | Chlorocebus sabaeus |
| CL | 17.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 40.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 40.0 | mL.min-1.g-1 | Homo sapiens |
| Ka | 9.558 | 10'5/Ms | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine